Qian W - Search Results

1

MiRNA-340-5p mediates the functional and infiltrative promotion of tumor-infiltrating CD8⁺ T lymphocytes in human diffuse large B cell lymphoma.

Xu Y, Liu Z, Lv L, Li P, Xiu B, Qian W, Liang A. Xu Y, et al. Among authors: qian w. J Exp Clin Cancer Res. 2020 Nov 10;39(1):238. doi: 10.1186/s13046-020-01752-2. J Exp Clin Cancer Res. 2020. PMID: 33168024 Free PMC article.

2

Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo.

Chen Z, You L, Wang L, Huang X, Liu H, Wei JY, Zhu L, Qian W. Chen Z, et al. Among authors: qian w. J Exp Clin Cancer Res. 2018 Aug 13;37(1):190. doi: 10.1186/s13046-018-0863-7. J Exp Clin Cancer Res. 2018. PMID: 30103789 Free PMC article.

3

Bypassing drug resistance by triggering necroptosis: recent advances in mechanisms and its therapeutic exploitation in leukemia.

Huang X, Xiao F, Li Y, Qian W, Ding W, Ye X. Huang X, et al. Among authors: qian w. J Exp Clin Cancer Res. 2018 Dec 12;37(1):310. doi: 10.1186/s13046-018-0976-z. J Exp Clin Cancer Res. 2018. PMID: 30541583 Free PMC article. Review.

4

Clinicopathologic significance and therapeutic implication of de novo CD5+ diffuse large B-cell lymphoma.

Tang H, Zhou H, Wei J, Liu H, Qian W, Chen X. Tang H, et al. Among authors: qian w. Hematology. 2019 Dec;24(1):446-454. doi: 10.1080/16078454.2019.1614289. Hematology. 2019. PMID: 31072235 Free article.

5

Prognostic and clinicopathological significance of PD-1/PD-L1 expression in the tumor microenvironment and neoplastic cells for lymphoma.

Xie M, Huang X, Ye X, Qian W. Xie M, et al. Among authors: qian w. Int Immunopharmacol. 2019 Dec;77:105999. doi: 10.1016/j.intimp.2019.105999. Epub 2019 Nov 6. Int Immunopharmacol. 2019. PMID: 31704289 Review.

6

Risk of HBV reactivation post CD19-CAR-T cell therapy in DLBCL patients with concomitant chronic HBV infection.

Yang C, Xie M, Zhang K, Liu H, Liang A, Young KH, Qian W. Yang C, et al. Among authors: qian w. Leukemia. 2020 Nov;34(11):3055-3059. doi: 10.1038/s41375-020-0913-y. Epub 2020 Jun 12. Leukemia. 2020. PMID: 32533094 No abstract available.

7

Prognostic value of tissue-infiltrating immune cells in tumor microenvironment of follicular lymphoma: A meta-analysis.

Xie M, Jiang Q, Zhao S, Zhao J, Ye X, Qian W. Xie M, et al. Among authors: qian w. Int Immunopharmacol. 2020 Aug;85:106684. doi: 10.1016/j.intimp.2020.106684. Epub 2020 Jun 12. Int Immunopharmacol. 2020. PMID: 32540726

8

The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma.

Wei J, Liu Y, Wang C, Zhang Y, Tong C, Dai G, Wang W, Rasko JEJ, Melenhorst JJ, Qian W, Liang A, Han W. Wei J, et al. Among authors: qian w. Signal Transduct Target Ther. 2020 Jul 29;5(1):134. doi: 10.1038/s41392-020-00256-x. Signal Transduct Target Ther. 2020. PMID: 32728035 Free PMC article. Review.

9

CD19-specific CAR T Cells that Express a PD-1/CD28 Chimeric Switch-Receptor are Effective in Patients with PD-L1-positive B-Cell Lymphoma.

Liu H, Lei W, Zhang C, Yang C, Wei J, Guo Q, Guo X, Chen Z, Lu Y, Young KH, Lu Z, Qian W. Liu H, et al. Among authors: qian w. Clin Cancer Res. 2021 Jan 15;27(2):473-484. doi: 10.1158/1078-0432.CCR-20-1457. Epub 2020 Oct 7. Clin Cancer Res. 2021. PMID: 33028589 Clinical Trial.

10

Sustained Remission of Relapsed or Refractory Mantle Cell Lymphoma After 4-1BB-Based CD19-Directed CAR-T Therapy.

Yang C, Lei W, Xie H, Wu G, Wei J, Liang A, Qian W. Yang C, et al. Among authors: qian w. Onco Targets Ther. 2020 Nov 25;13:12163-12168. doi: 10.2147/OTT.S280535. eCollection 2020. Onco Targets Ther. 2020. PMID: 33268994 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,216 results

Search Page

Filters